Literature DB >> 18677272

Steroids in otolaryngology.

Daron Cope1, Ronaldo Bova.   

Abstract

Steroids are increasingly being used to treat a wide spectrum of otolaryngological disorders. It is important for ear-nose-throat surgeons to understand the short- and long-term complications associated with steroid use. The aim of this study was to review the role of steroids in common ear-nose-throat disorders. Corticosteroid therapy has been shown to be effective in the management of idiopathic facial nerve palsy, allergic rhinitis, acute sinusitis, sinonasal inflammatory polyposis, and croup. The therapeutic efficacy of steroids in the management of Meniere's disease, sudden idiopathic sensorineural HL, chronic otitis media, and vestibular neuronitis remain controversial.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677272     DOI: 10.1097/MLG.0b013e31817c0b4d

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

Review 1.  Optimization of the Surgical Field in Endoscopic Sinus Surgery: an Evidence-Based Approach.

Authors:  Saad Alsaleh; Jamil Manji; Amin Javer
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-02       Impact factor: 4.806

Review 2.  Contemporary Use of Corticosteroids in Rhinology.

Authors:  Alexander Karatzanis; Alkiviadis Chatzidakis; Athanasia Milioni; Stephan Vlaminck; Hideyuki Kawauchi; Stylianos Velegrakis; Emmanuel Prokopakis
Journal:  Curr Allergy Asthma Rep       Date:  2017-02       Impact factor: 4.806

3.  Efficacy of steroid therapy based on symptomatic and functional improvement in patients with vestibular neuritis: a prospective randomized controlled trial.

Authors:  Myung Hoon Yoo; Chan Joo Yang; Shin Ae Kim; Marn Joon Park; Joong Ho Ahn; Jong Woo Chung; Hong Ju Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-08       Impact factor: 2.503

4.  Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects.

Authors:  Clemens Honeder; Elisabeth Engleder; Hanna Schöpper; Markus Krause; Lukas David Landegger; Roberto Plasenzotti; Franz Gabor; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  Laryngoscope       Date:  2014-11-10       Impact factor: 3.325

5.  Interleukin-1β regulates the expression of glucocorticoid receptor isoforms in nasal polyps in vitro via p38 MAPK and JNK signal transduction pathways.

Authors:  Zhenlin Wang; Peng Li; Qiuhang Zhang; Haili Lv; Junqi Liu; Jinyuan Si
Journal:  J Inflamm (Lond)       Date:  2015-01-20       Impact factor: 4.981

6.  Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A.

Authors:  Lukas D Landegger; Clemens Honeder; Chengjing Zhu; Hanna Schöpper; Elisabeth Engleder; Franz Gabor; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  J Negat Results Biomed       Date:  2016-05-11

7.  Effects of intraoperatively applied glucocorticoid hydrogels on residual hearing and foreign body reaction in a guinea pig model of cochlear implantation.

Authors:  Clemens Honeder; Lukas David Landegger; Elisabeth Engleder; Franz Gabor; Roberto Plasenzotti; Hanns Plenk; Alexandra Kaider; Lena Hirtler; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  Acta Otolaryngol       Date:  2015-02-26       Impact factor: 1.494

8.  Intranasal Corticosteroids: Patient Administration Angles and Impact of Education.

Authors:  Sara Treat; Charles S Ebert; Zainab Farzal; Saikat Basu; Adam M Zanation; Brian D Thorp; Julia S Kimbell; Brent A Senior; Adam J Kimple
Journal:  Rhinol Online       Date:  2020-11-08

9.  Bioabsorbable steroid-releasing sinus implants in the frontal and maxillary sinuses: 2-year follow-up.

Authors:  Keith E Matheny
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

Review 10.  The Efficacy of Corticosteroids in the Treatment of Peritonsillar Abscess: A Meta-Analysis.

Authors:  Yeon Ji Lee; Yeon Min Jeong; Ho Seok Lee; Se Hwan Hwang
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-04-19       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.